Cargando…

The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages

The transformation of macrophages into lipid-loaded foam cells is a critical early event in the pathogenesis of atherosclerosis. Both receptor-mediated uptake of modified LDL, mediated primarily by scavenger receptors-A (SR-A) and CD36 along with other proteins such as lipoprotein lipase (LPL), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, Daryn R., Davies, Thomas S., Laubertová, Lucia, Gallagher, Hayley, Ramji, Dipak P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339697/
https://www.ncbi.nlm.nih.gov/pubmed/25663263
http://dx.doi.org/10.1007/s11745-015-3993-0
_version_ 1782358901561229312
author Michael, Daryn R.
Davies, Thomas S.
Laubertová, Lucia
Gallagher, Hayley
Ramji, Dipak P.
author_facet Michael, Daryn R.
Davies, Thomas S.
Laubertová, Lucia
Gallagher, Hayley
Ramji, Dipak P.
author_sort Michael, Daryn R.
collection PubMed
description The transformation of macrophages into lipid-loaded foam cells is a critical early event in the pathogenesis of atherosclerosis. Both receptor-mediated uptake of modified LDL, mediated primarily by scavenger receptors-A (SR-A) and CD36 along with other proteins such as lipoprotein lipase (LPL), and macropinocytosis contribute to macrophage foam cell formation. The signaling pathways that are involved in the control of foam cell formation are not fully understood. In this study, we have investigated the role of phosphoinositide 3-kinase (PI3K) in relation to foam cell formation in human macrophages. The pan PI3K inhibitor LY294002 attenuated the uptake of modified LDL and macropinocytosis, as measured by Lucifer Yellow uptake, by human macrophages. In addition, the expression of SR-A, CD36 and LPL was attenuated by LY294002. The use of isoform-selective PI3K inhibitors showed that PI3K-β, -γ and -δ were all required for the expression of SR-A and CD36 whereas only PI3K-γ was necessary in the case of LPL. These studies reveal a pivotal role of PI3K in the control of macrophage foam cell formation and provide further evidence for their potential as therapeutic target against atherosclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11745-015-3993-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4339697
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43396972015-03-02 The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages Michael, Daryn R. Davies, Thomas S. Laubertová, Lucia Gallagher, Hayley Ramji, Dipak P. Lipids Original Article The transformation of macrophages into lipid-loaded foam cells is a critical early event in the pathogenesis of atherosclerosis. Both receptor-mediated uptake of modified LDL, mediated primarily by scavenger receptors-A (SR-A) and CD36 along with other proteins such as lipoprotein lipase (LPL), and macropinocytosis contribute to macrophage foam cell formation. The signaling pathways that are involved in the control of foam cell formation are not fully understood. In this study, we have investigated the role of phosphoinositide 3-kinase (PI3K) in relation to foam cell formation in human macrophages. The pan PI3K inhibitor LY294002 attenuated the uptake of modified LDL and macropinocytosis, as measured by Lucifer Yellow uptake, by human macrophages. In addition, the expression of SR-A, CD36 and LPL was attenuated by LY294002. The use of isoform-selective PI3K inhibitors showed that PI3K-β, -γ and -δ were all required for the expression of SR-A and CD36 whereas only PI3K-γ was necessary in the case of LPL. These studies reveal a pivotal role of PI3K in the control of macrophage foam cell formation and provide further evidence for their potential as therapeutic target against atherosclerosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11745-015-3993-0) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-02-08 2015 /pmc/articles/PMC4339697/ /pubmed/25663263 http://dx.doi.org/10.1007/s11745-015-3993-0 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Michael, Daryn R.
Davies, Thomas S.
Laubertová, Lucia
Gallagher, Hayley
Ramji, Dipak P.
The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title_full The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title_fullStr The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title_full_unstemmed The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title_short The Phosphoinositide 3-Kinase Signaling Pathway is Involved in the Control of Modified Low-Density Lipoprotein Uptake by Human Macrophages
title_sort phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophages
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339697/
https://www.ncbi.nlm.nih.gov/pubmed/25663263
http://dx.doi.org/10.1007/s11745-015-3993-0
work_keys_str_mv AT michaeldarynr thephosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT daviesthomass thephosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT laubertovalucia thephosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT gallagherhayley thephosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT ramjidipakp thephosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT michaeldarynr phosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT daviesthomass phosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT laubertovalucia phosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT gallagherhayley phosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages
AT ramjidipakp phosphoinositide3kinasesignalingpathwayisinvolvedinthecontrolofmodifiedlowdensitylipoproteinuptakebyhumanmacrophages